Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 0 | Kelly John AlexanderChief Financial Officer | Option exercise · 10b5-1 plan | M | — 3,888 sh |
| Jan 22, 2026 traded Jan 20, 2026 |
| 0 | Sheena JonathanDirector, CO-FOUNDER | Option exercise · 10b5-1 plan | M | — 191 sh | Jan 22, 2026 traded Jan 20, 2026 |
| 0 | Gibson ChristopherDirector | Derivative conversion · 10b5-1 plan | C | — 40.0K sh | Jan 22, 2026 traded Jan 20, 2026 |
| 0 | Vanderhook TimothyDirector, CEO and Chairman, 10% Owner | Disposition to issuer · 10b5-1 plan | D | — 12.5K sh | Jan 22, 2026 traded Jan 20, 2026 |
| 0 | Vanderhook TimothyDirector, CEO and Chairman, 10% Owner | Option exercise · 10b5-1 plan | M | — 12.5K sh | Jan 22, 2026 traded Jan 20, 2026 |
| 0 | O'Connor CaseyChief Legal Officer | Option exercise · 10b5-1 plan | M | — 13.6K sh | Jan 22, 2026 traded Jan 20, 2026 |
| 0 | Brown Sam D.SEVP, Chief Banking Officer | Tax withholding · 10b5-1 plan | F | $49K 1,524 sh | Jan 22, 2026 traded Jan 20, 2026 |
| 0 | McBee BranninChief Development Officer | Derivative conversion · 10b5-1 plan | C | — 8,335 sh | Jan 22, 2026 traded Jan 20, 2026 |
| 0 | Goel Rajeev K.Director, CHIEF EXECUTIVE OFFICER, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 44.0K sh | Jan 22, 2026 traded Jan 20, 2026 |
| 62 | Brakewood Harold EugeneChief Business Officer | Open-market purchase | BUY | $25K 5,250 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 52 | Marantz Jing L.CHIEF MEDICAL OFFICER | Open-market sale | SELL | $258K 5,798 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 48 | Small MartinCFO & Senior Managing Director | Open-market sale | SELL | $15.09M 12.9K sh | Jan 21, 2026 traded Jan 16, 2026 |
| 48 | Ho JunlinGENERAL COUNSEL | Open-market sale | SELL | $357K 8,016 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 48 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Open-market sale | SELL | $374K 8,406 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 48 | Parlavecchio CarynCHRO | Open-market sale | SELL | $294K 6,600 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 45 | Small MartinCFO & Senior Managing Director | Open-market sale | SELL | $9.54M 8,139 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 45 | Small MartinCFO & Senior Managing Director | Open-market sale | SELL | $6.46M 5,514 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 36 | Attal AlainDirector | Open-market purchase | BUY | $260K 12.0K sh | Jan 21, 2026 traded Jan 21, 2026 |
| 35 | Small MartinCFO & Senior Managing Director | Option exercise | M | $13.89M 27.0K sh | Jan 21, 2026 traded Jan 16, 2026 |
| 34 | Small MartinCFO & Senior Managing Director | Open-market sale | SELL | $590K 503 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 33 | Harmon CyrusDirector | Open-market sale | SELL | $269K 10.0K sh | Jan 21, 2026 traded Jan 20, 2026 |
| 31 | Ways Douglas KirkDirector, Interim Chief Medical Officer | Option exercise | M | — 1,250 sh | Jan 21, 2026 traded Dec 11, 2025 |
| 30 | Wollin Robert JGENERAL COUNSEL AND SECRETARY | Tax withholding | F | $202K 27.2K sh | Jan 21, 2026 traded Jan 17, 2026 |
| 30 | Weitzel Gregory ThomasCFO | Disposition to issuer | D | $113K 9,003 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 30 | Exicure HiTron Inc.10% Owner | Open-market sale | SELL | $1.16M 258.4K sh | Jan 21, 2026 traded Jan 21, 2026 |
| 29 | Selecky ChristobelDirector | Open-market sale · 10b5-1 plan | SELL | $250K 50.0K sh | Jan 21, 2026 traded Jan 16, 2026 |
| 27 | Gerrity Robert WDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $610K 31.5K sh | Jan 21, 2026 traded Jan 16, 2026 |
| 27 | DeSantis Deborah10% Owner | Other acquisition or disposition | J | $4.65M 120.0K sh | Jan 21, 2026 traded Jan 16, 2026 |
| 27 | Senn AndrewSVP, Strategy and Business Dev | Option exercise | M | — 630 sh | Jan 21, 2026 traded Jan 17, 2026 |
| 27 | Hazelbaker JillSee Remarks | Option exercise | M | — 2,689 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 27 | Cohen StephenSenior Managing Director | Grant or award | A | — 2,596 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 27 | Fleming Gregory JDirector | Grant or award | A | — 214 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 27 | Macdonald AndrewSee Remarks | Option exercise | M | — 3,841 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 27 | Krishnamurthy NikkiSVP and Chief People Officer | Option exercise | M | — 2,113 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 27 | Weitzel Gregory ThomasCFO | Grant or award | A | — 24.1K sh | Jan 21, 2026 traded Jan 16, 2026 |
| 27 | Wollin Robert JGENERAL COUNSEL AND SECRETARY | Option exercise | M | — 50.0K sh | Jan 21, 2026 traded Jan 17, 2026 |
| 27 | DeSantis Dean10% Owner | Other acquisition or disposition | J | $4.65M 120.0K sh | Jan 21, 2026 traded Jan 16, 2026 |
| 27 | Milmoe William H.10% Owner | Other acquisition or disposition | J | $4.65M 120.0K sh | Jan 21, 2026 traded Jan 16, 2026 |
| 27 | Stephens JimPresident, CRM & Neuro | Option exercise | M | — 748 sh | Jan 21, 2026 traded Jan 17, 2026 |
| 27 | Weitzel Gregory ThomasCFO | Grant or award | A | — 27.5K sh | Jan 21, 2026 traded Jan 16, 2026 |